Someplace on the planet, someone needs specific medicine to improve or save their life. Unfortunately, these medications are often available in one country but not in another due to regulatory barriers. Ikris Pharma Network (IPN) is dedicated to bridging this gap, ensuring that patients have access to potentially life-saving treatments through our program called Global Managed Access Programs.

At Ikris Pharma Network, we understand the personal impact of limited access to essential medications. Our mission is to ensure that everyone, regardless of their location, has equal and fair access to quality medicines. We operate in over 150 countries and have successfully assisted thousands of patients in obtaining necessary treatments through our Named Patient Import Service.

Our Mission:

Our primary goal is to serve as a portal that connects patients with the hard-to-access medications they need. We focus on individual patients, working closely with their healthcare professionals to facilitate the import of life-saving, unlicensed or unapproved drugs under specific conditions, including:

• The medication has market approval in another country but is unapproved or unavailable in the patient’s home country.
• No alternative treatments are available in the local market.
• The medication is for personal use.
• The patient has a valid prescription from their doctor.
   

Programs and Regulations:

Each country has its own regulations regarding access and import of advanced medicines. Some of the key programs include:

• Named Patient Import
• Early Access Programme
• Compassionate Use Programme
   

For instance, medicine access programs in Brazil, like the "Programa de Acesso Expandido," allow patients to access drugs that have not yet been approved locally but are essential for treating life-threatening conditions. Managed Access Programs in India and Bulgaria are designed to help patients get advanced medications through legal channels.

Our Approach:

Ikris Pharma Network (IPN) is a legally recognized company that follows strict guidelines laid out by the Ministries of Health, Named Patient programs, and customs agencies. We meticulously select our suppliers based on product quality and stock reliability, negotiating the best prices to pass savings on to patients.

Through our Named Patient Import service in India, Africa, Brazil, and Europe, we guide patients in consultation with their healthcare providers to determine the best course of treatment. Once a valid prescription is obtained, we manage all subsequent steps, including sourcing, shipping, customs clearance, and delivery, while ensuring everything is received correctly.

With our warehouse facilities in Bulgaria and Belgium, we can rapidly move hard-to-access, unlicensed, or unapproved drugs anywhere on the planet.

Empowering Patients:

As a trusted Named patient program supplier in India, we believe in empowering patients by providing comprehensive information about their options. By understanding their rights and the available medicine access programs, patients can make informed decisions and initiate positive change in their healthcare journey.

At Ikris Pharma Network (IPN), our commitment is to connect individuals worldwide with the advanced healthcare they deserve, offering hope and a better quality of life (QoL) for all. Contact us today to learn more about our offering.